News
Moses Itauma looks to take the next step in his promising journey as he faces off against fellow British heavyweight Dillian ...
In recent years, men’s health has shifted from being a quiet, private matter to an open conversation fueled by technology and ...
The summary covers recent significant developments in health news including Warren Buffett's Berkshire Hathaway's investment in UnitedHealth Group and the struggles of the UK's bioethanol industry due ...
Hims & Hers saw 73% revenue growth, driven by subscriber gains and ARPU hikes. Read here for an in-depth investment analysis ...
Investors with substantial losses have the opportunity (until August 25, 2025) to move the court for appointment as Lead Plaintiff. Shareholder rights firm Hagens Berman is investigating the legal ...
Recent health-related developments include Britain's decisions on the bioethanol industry, Berkshire Hathaway's new stake in ...
19h
TipRanks on MSNBullish flow in Novo Nordisk with shares up 2.99%
Bullish flow in Novo Nordisk (NVO), with shares up $1.52, or 2.99%, near $52.48. Options volume roughly in line with average with 102k contracts ...
Children were reportedly hospitalized after starting treatment. Scorpion Capital suggests Soleno's medication could face ...
U.S. equities were mixed at midday following the release of the July retail sales report, which came in as expected.
HIMS investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
US FTC Investigating Hims & Hers Over Advertising and Cancellation Practices, Bloomberg News Reports
A spokesperson for Hims did not immediately respond to a request for comment. The company previously said it was cooperating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results